Direct Cytoplasmic Transcription and Trimeric RBD Design Synergize to Enhance DNA Vaccine Potency Against SARS-CoV-2.
Saved in:
| Title: | Direct Cytoplasmic Transcription and Trimeric RBD Design Synergize to Enhance DNA Vaccine Potency Against SARS-CoV-2. |
|---|---|
| Authors: | Nam Y; Medicinal Materials Research Center, Biomedical Research Institute, Korea Institute of Science and Technology, Seoul 02792, Republic of Korea., Shin SC; Technological Convergence Center, Research Resources Division, Korea Institute of Science and Technology, Seoul 02792, Republic of Korea., Cho SW; Medicinal Materials Research Center, Biomedical Research Institute, Korea Institute of Science and Technology, Seoul 02792, Republic of Korea., Ahn HJ; Medicinal Materials Research Center, Biomedical Research Institute, Korea Institute of Science and Technology, Seoul 02792, Republic of Korea. |
| Source: | Pharmaceutics [Pharmaceutics] 2026 Jan 26; Vol. 18 (2). Date of Electronic Publication: 2026 Jan 26. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101534003 Publication Model: Electronic Cited Medium: Print ISSN: 1999-4923 (Print) Linking ISSN: 19994923 NLM ISO Abbreviation: Pharmaceutics Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1999-4923 |
|---|---|
| DOI: | 10.3390/pharmaceutics18020164 |
